AtaiBeckley (ATAI) Net Income (2020 - 2026)
AtaiBeckley (ATAI) reported Net Income of -$61.1 million for Q3 2025, down 129.03% on a YoY basis from $210.3 million in Q3 2024, and down 120.04% sequentially from -$27.8 million in Q2 2025.
AtaiBeckley (ATAI) Net Income (2020 - 2026) Analysis & Trends
AtaiBeckley's Net Income history runs 2 years deep, the most recent figure standing at -$29.8 million for Q1 2026.
- On a quarterly basis, Net Income fell 12.61% year-over-year to -$29.8 million in Q1 2026; TTM through Mar 2026 was -$56.3 million, a N/A change from a year earlier, with the FY2025 full-year figure at -$659.9 million, down 344.64% from the prior year.
- Net Income eased to -$61.1 million in Q3 2025, from -$27.8 million in the prior quarter.
- Across five years, Net Income topped out at -$26.5 million in Q1 2025 and bottomed at -$29.8 million in Q1 2026.
- A 5-year average of -$30.4 million and a median of -$31.8 million in 2023 frame the typical range for Net Income.
- Across the five-year window, Net Income slumped 842.61% in 2021 and jumped 231.22% in 2023, its largest moves.
- Tracing ATAI's Net Income over 5 years: stood at -$49.3 million in 2021, then advanced by 18.3% to -$40.3 million in 2022, then soared by 53.45% to -$18.7 million in 2023, then sank by 107.97% to -$39.0 million in 2024, then sank by 56.62% to -$61.1 million in 2025.
- Business Quant data shows ATAI's Net Income at -$61.1 million in Q3 2025, -$27.8 million in Q2 2025, and -$26.5 million in Q1 2025.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Net Income (Qtr) |
|---|---|---|---|---|---|
| 1 | Oculis Holding AG | 68,785.72 Bn | 68,785.72 Bn | - | -37.09 Mn |
| 2 | Nanobiotix | 1,895.57 Bn | 1,895.51 Bn | - | - |
| 3 | BeOne Medicines | 471.35 Bn | 466.56 Bn | 1.35 Bn | 227.36 Mn |
| 4 | NuCana | 279.75 Bn | 279.75 Bn | - | -3.31 Mn |
| 5 | Vertex Pharmaceuticals | 120.24 Bn | 113.00 Bn | 2.59 Bn | 1.03 Bn |
| 6 | Regeneron Pharmaceuticals | 67.80 Bn | 59.04 Bn | 3.31 Bn | 727.20 Mn |
| 7 | Belite Bio | 62.51 Bn | 62.51 Bn | - | -26.94 Mn |
| 8 | Argenx Se | 57.38 Bn | 57.38 Bn | 1.41 Bn | 362.00 Mn |
| 9 | Revolution Medicines | 37.78 Bn | 37.78 Bn | - | -453.82 Mn |
| 10 | AtaiBeckley | 2.56 Bn | 2.56 Bn | - | -61.07 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | -29.80 Mn |
| Sep 30, 2025 | -61.07 Mn |
| Jun 30, 2025 | -27.75 Mn |
| Mar 31, 2025 | -26.47 Mn |
| Mar 31, 2025 | -26.47 Mn |
| Dec 31, 2024 | -38.99 Mn |
| Sep 30, 2024 | -26.66 Mn |
| Jun 30, 2024 | -57.10 Mn |
| Mar 31, 2024 | -25.68 Mn |
| Dec 31, 2023 | -18.75 Mn |
| Sep 30, 2023 | 43.61 Mn |
| Jun 30, 2023 | -31.84 Mn |
| Mar 31, 2023 | -33.36 Mn |
| Dec 31, 2022 | -40.28 Mn |
| Sep 30, 2022 | -33.23 Mn |
| Jun 30, 2022 | -30.86 Mn |
| Mar 31, 2022 | -31.96 Mn |
| Dec 31, 2021 | -49.30 Mn |
| Sep 30, 2021 | -26.87 Mn |
| Jun 30, 2021 | -67.36 Mn |